ScoreComparison
Company
Score
Quality
Valuation
Financial
Technical
Why is USANA Health Sciences, Inc. ?
1
The company has declared negative results for the last 7 consecutive quarters
- INTEREST(HY) At USD 0.67 MM has Grown at 550.49%
- OPERATING CASH FLOW(Y) Lowest at USD 63.01 MM
- NET PROFIT(HY) At USD 19.06 MM has Grown at -29.34%
2
With ROE of 6.57%, it has a attractive valuation with a 1.03 Price to Book Value
- The stock is trading at a premium compared to its peers' average historical valuations
- Over the past year, while the stock has generated a return of -49.21%, its profits have fallen by -43.8%
3
Consistent Underperformance against the benchmark over the last 3 years
- Along with generating -49.21% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is USANA Health Sciences, Inc. for you?
High Risk, Low Return
Absolute
Risk Adjusted
Volatility
USANA Health Sciences, Inc.
-49.21%
-1.23
47.31%
S&P 500
13.22%
0.65
20.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
-3.19%
EBIT Growth (5y)
-18.74%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.30
Sales to Capital Employed (avg)
1.77
Tax Ratio
47.24%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
61.30%
ROCE (avg)
70.81%
ROE (avg)
18.61%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
1.03
EV to EBIT
6.81
EV to EBITDA
4.61
EV to Capital Employed
1.05
EV to Sales
0.45
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
15.36%
ROE (Latest)
6.57%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
Bullish
No Signal
Bollinger Bands
Mildly Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Bearish
Dow Theory
Mildly Bullish
Mildly Bearish
OBV
Mildly Bearish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend2What is working for the Company
OPERATING PROFIT(Q)
Highest at USD 26.32 MM
OPERATING PROFIT MARGIN(Q)
Highest at 11.16 %
-20What is not working for the Company
INTEREST(HY)
At USD 0.67 MM has Grown at 550.49%
OPERATING CASH FLOW(Y)
Lowest at USD 63.01 MM
NET PROFIT(HY)
At USD 19.06 MM has Grown at -29.34%
ROCE(HY)
Lowest at 6.54%
CASH AND EQV(HY)
Lowest at USD 330.95 MM
Here's what is working for USANA Health Sciences, Inc.
Operating Profit
Highest at USD 26.32 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is positive
Operating Profit (USD MM)
Operating Profit Margin
Highest at 11.16 %
in the last five periodsMOJO Watch
Company's profit margin has improved
Operating Profit to Sales
Here's what is not working for USANA Health Sciences, Inc.
Interest
At USD 0.67 MM has Grown at 550.49%
over previous Semi-Annual periodMOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (USD MM)
Operating Cash Flow
Lowest at USD 63.01 MM and Fallen
In each year in the last three yearsMOJO Watch
The company's cash revenues from business operations are falling
Operating Cash Flows (USD MM)
Net Profit
At USD 19.06 MM has Grown at -29.34%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is negative
Net Profit (USD MM)
Cash and Eqv
Lowest at USD 330.95 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is deteriorating
Cash and Cash Equivalents
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
